HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic implications of a molecular classifier derived from whole-exome sequencing in nasopharyngeal carcinoma.

Abstract
The aim of this study was to use whole-exome sequencing to derive a molecular classifier for nasopharyngeal carcinoma (NPC) and evaluate its clinical performance. We performed whole-exome sequencing on 82 primary NPC tumors from Sun Yat-sen University Cancer Center (Guangzhou cohort) to obtain somatic single-nucleotide variants, indels, and copy number variants. A novel molecular classifier was then developed and validated in another NPC cohort (Hong Kong cohort, n = 99). Survival analysis was estimated by the Kaplan-Meier method and compared using the log-rank test. Cox proportional hazards model was adopted for univariate and multivariate analyses. We identified three prominent NPC genetic subtypes: RAS/PI3K/AKT (based on RAS, AKT1, and PIK3CA mutations), cell-cycle (based on CDKN2A/CDKN2B deletions, and CDKN1B and CCND1 amplifications), and unclassified (based on dominant mutations in epigenetic regulators, such as KMT2C/2D, or the Notch signaling pathway, such as NOTCH1/2). These subtypes differed in survival analysis, with good, intermediate, and poor progression-free survival in the unclassified, cell-cycle, and RAS/PI3K/AKT subgroups, respectively, among the Guangzhou, Hong Kong, and combined cohorts (n = 82, P = 0.0342; n = 99, P = 0.0372; and n = 181, P = 0.0023; log-rank test). We have uncovered genetic subtypes of NPC with distinct mutations and/or copy number changes, reflecting discrete paths of NPC tumorigenesis and providing a roadmap for developing new prognostic biomarkers and targeted therapies.
AuthorsHai-Yun Wang, Fugen Li, Na Liu, Xiao-Yun Liu, Xin-Hua Yang, Yun-Miao Guo, Jin-Xin Bei, Yi-Xin Zeng, Jian-Yong Shao
JournalCancer medicine (Cancer Med) Vol. 8 Issue 6 Pg. 2705-2716 (06 2019) ISSN: 2045-7634 [Electronic] United States
PMID30950204 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Chemical References
  • Biomarkers, Tumor
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor
  • Cell Transformation, Neoplastic (genetics)
  • Chromosomal Instability
  • Computational Biology
  • DNA Copy Number Variations
  • Female
  • Gene Expression Profiling
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Mutation
  • Nasopharyngeal Carcinoma (diagnosis, genetics, metabolism, mortality)
  • Neoplasm Staging
  • Polymorphism, Single Nucleotide
  • Prognosis
  • Signal Transduction
  • Exome Sequencing
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: